Title : Resveratrol inhibits proliferation of hypoxic choroidal vascular endothelial cells.

Pub. Date : 2013

PMID : 24319332






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The effect of resveratrol on hypoxia-induced vascular endothelial growth factor (VEGF) release was analyzed with enzyme-linked immunosorbent assay. Resveratrol vascular endothelial growth factor A Homo sapiens
2 The effect of resveratrol on hypoxia-induced vascular endothelial growth factor (VEGF) release was analyzed with enzyme-linked immunosorbent assay. Resveratrol vascular endothelial growth factor A Homo sapiens
3 Hypoxia-induced VEGF release (30.9+-2.6 pg/ml) was inhibited in a dose-dependent fashion by 2, 4, 6, 8, 10, and 12 mug/ml resveratrol to 12.4+-2.1, 11.0+-1.9, 10.3+-3.0, 7.5+-1.9, 5.5+-2.0, and 5.5+-2.3 pg/ml, respectively. Resveratrol vascular endothelial growth factor A Homo sapiens
4 Resveratrol, a nutritional supplement and inhibitor of CVECs, may be a useful adjunct to current anti-VEGF therapy in wet age-related macular degeneration. Resveratrol vascular endothelial growth factor A Homo sapiens